As PartnersLTD Valuation
Is 160A undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Book vs Peers
Price-To-Book vs Industry
Price-To-Book vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 160A when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 160A (¥1789) is trading above our estimate of fair value (¥1462.43)
Significantly Below Fair Value: 160A is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 160A?
Key metric: As 160A is unprofitable and pre-revenue we use its Price-To-Book Ratio for relative valuation analysis.
| What is 160A's PB Ratio? | |
|---|---|
| PB Ratio | n/a |
| Book | JP¥0 |
| Market Cap | JP¥6.12b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | n/a |
| Enterprise Value/EBITDA | n/a |
| PEG Ratio | n/a |
Price to Book Ratio vs Peers
How does 160A's PB Ratio compare to its peers?
| Company | Forward PB | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 2.4x | ||
194A WOLVES HAND | 2.8x | n/a | JP¥5.9b |
6039 Japan Animal Referral Medical Center | 1.5x | 15.8% | JP¥5.7b |
7061 Japan Hospice Holdings | 3.7x | 35.6% | JP¥11.1b |
6545 internet infinity | 1.8x | 19.0% | JP¥2.7b |
160A As PartnersLTD | n/a | n/a | JP¥6.1b |
Price-To-Book vs Peers: Insufficient data to calculate 160A's Price-To-Book Ratio vs. peers for valuation analysis.
Price to Book Ratio vs Industry
How does 160A's PB Ratio compare vs other companies in the JP Healthcare Industry?
| 1 Company | Price / Book | Estimated Growth | Market Cap |
|---|---|---|---|
| 1 Company | Estimated Growth | Market Cap | |
|---|---|---|---|
Price-To-Book vs Industry: Insufficient data to calculate 160A's Price-To-Book Ratio vs. industry for valuation analysis.
Price to Book Ratio vs Fair Ratio
What is 160A's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PB Ratio | n/a |
| Fair PB Ratio | n/a |
Price-To-Book vs Fair Ratio: Insufficient data to calculate 160A's Price-To-Book Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
FINDEX
JP¥20.5b
Offers medical systems, office systems, and Healthtech products in Japan.
3649
JP¥800.00
7D
-0.7%
1Y
-12.5%
Daiken Medical
JP¥14.7b
Engages in the manufacture and distribution of medical devices and equipment in Japan and internationally.
7775
JP¥511.00
7D
1.4%
1Y
-1.4%
Charm Care
JP¥40.4b
Engages in nursing care business.
6062
JP¥1,238.00
7D
2.1%
1Y
4.5%